Piramal Pharma announces leadership change at Critical Care division

Kmp ResignedManagement Changes View source PDF Explain this filing

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.7%Reaction day

₹206.00

prior close

₹205.70

announcement price

After-mkt

timing

Nifty Smallcap 250market-1.2%-2.6% vs market

Pharmaceuticals peers, median of 173sector-0.8%-2.9% vs sector

On the reaction day the stock moved 2.6 pts less than Nifty Smallcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.9

15m

-1.5

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.7-1.2-2.6-0.8-2.9

Next day

-5.5-0.8-4.7-1.2-4.2

-2.5+0.6-3.1-0.4-2.1

-1.3+0.7-2.0-0.1-1.2

-4.9-1.7-3.1-3.0-1.8

-4.3-1.3-3.0-3.1-1.2

-4.8+0.2-5.0-3.0-1.8

15d

-5.4-6.9+1.5-7.1+1.7

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Piramal Pharma announced that Mr. Jeffrey Hampton, President and COO of Piramal Critical Care, will retire on 27 November 2026. The board has approved Mr. Brian Guy as his successor, effective 19 October 2026. Mr. Guy brings over 25 years of pharma industry experience, currently serving as President and Chief Commercial Officer of Breckenridge Pharmaceutical Inc.

Likely market impact

Routine senior management transition at Critical Care division, with an experienced external successor lined up for smooth handover.